Cancer statistics, 2023

Siegel, Rebecca L., Miller, Kimberly D., Wagle, Nikita Sandeep, Jemal, Ahmedin·2023·CA: A Cancer Journal for Clinicians
DOI 10.3322/caac.21763

Cited by (1,028)

Items 301–400 of 1,028

  1. Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets
    Zihong Wu, Chong Xiao, Jing Long, Wenbo Huang, Fengming You, Xueke Li · 2024 · Cell Communication and Signaling
  2. BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
    Sarah Lidagoster, Reuben Ben‐David, Benjamin De Leon, John P. Sfakianos · 2024 · Current Oncology
  3. Enhanced delivery of doxorubicin for breast cancer treatment using pH-sensitive starch/PVA/g-C3N4 hydrogel
    Parisa Alipournazari, Mehrab Pourmadadi, Majid Abdouss, Abbas Rahdar, Sadanand Pandey · 2024 · International Journal of Biological Macromolecules
  4. Increased perfluorooctanoic acid accumulation facilitates the migration and invasion of lung cancer cells via remodeling cell mechanics
    Jie Mei, Jipeng Jiang, Li Zhao, Yue Pan, Ke Xu, Xinglong Gao, Jing Yuan, Lili Li, Yufei Wang, Liuxiang Wang et al. · 2024 · Proceedings of the National Academy of Sciences
  5. Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
    Bi Lian, Xiaosong Chen, Kunwei Shen · 2023 · Frontiers in Immunology
  6. Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
    Francesco M. Lasorsa, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Riccardo Autorino B, Michele Battaglia, Pasquale Ditonno, Giuseppe Tiziano Lucarelli · 2023 · International Journal of Molecular Sciences
  7. Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision
    Rosita van den Puttelaar, Pedro Nascimento de Lima, Amy B. Knudsen, Carolyn M. Rutter, Karen M. Kuntz, Lucie de Jonge, Fernando Alarid‐Escudero, David A. Lieberman, Ann Graham Zauber, Anne I. Hahn et al. · 2024 · Gastroenterology
  8. Advancements of radiotherapy for recurrent head and neck cancer in modern era
    Shu Zhang, Ni Zeng, Jianping Yang, Jinlan He, Fubin Zhu, Wenjun Liao, Maoqi Xiong, Yan Li · 2023 · Radiation Oncology
  9. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma
    Chuxu Zhu, Kai Yan, Liang Chen, Rongrong Huang, Zhen-Hua Bian, Hao-Ran Wei, Xuemei Gu, Yang-Yang Zhao, Meng-Chu Liu, Caixia Suo et al. · 2024 · Journal of Hepatology
  10. Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients
    Weimin Caii, Xiao Hua Wu, Kun Guo, Yongxian Chen, Yubo Shi, Junkai Chen · 2024 · Cancer Immunology Immunotherapy
  11. Biotin-functionalized nanoparticles: an overview of recent trends in cancer detection
    Sonia Fathi‐karkan, Saman Sargazi, Shirin Shojaei, Bahareh Farasati Far, Shekoufeh Mirinejad, Marco Cordani, Arezoo Khosravi, Ali Zarrabi, Saeid Ghavami · 2024 · Nanoscale
  12. Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis
    Paul M. Cinciripini, George Kypriotakis, Janice A. Blalock, Maher Karam‐Hage, Diane Beneventi, Jason D. Robinson, Jennifer A. Minnix, Graham Walter Warren · 2024 · JAMA Oncology
  13. Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
    Shivan Sivakumar, Ashwin Jainarayanan, Edward H. Arbe-Barnes, Piyush Kumar Sharma, Máire Ní Leathlobhair, Sakina Amin, David J. Reiss, Lara Rosaline Heij, Samarth Hegde, Assaf Magen et al. · 2025 · Nature Communications
  14. Disparities in Lung Cancer: A Targeted Literature Review Examining Lung Cancer Screening, Diagnosis, Treatment, and Survival Outcomes in the United States
    Lisa L. Dwyer, Pratyusha Vadagam, Julie Vanderpoel, Carol Cohen, Benjamin Lewing, Joseph P. Tkacz · 2023 · Journal of Racial and Ethnic Health Disparities
  15. Hormone receptors in breast cancer: An update on the uncommon subtypes
    Shi Wei · 2023 · Pathology - Research and Practice
  16. The emerging role of PANoptosis in cancer treatment
    Yongai Xiong · 2023 · Biomedicine & Pharmacotherapy
  17. miRNAs in pancreatic cancer progression and metastasis
    Ellie T. Y. Mok, Jessica L. Chitty, Thomas R. Cox · 2024 · Clinical & Experimental Metastasis
  18. A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma
    Manyuan Li, Xufeng Deng, Dong Zhou, Xiaoqing Liu, Jigang Dai, Quanxing Liu · 2024 · Current Genomics
  19. Melanoma biology and treatment: a review of novel regulated cell death-based approaches
    Ming-yun Hsieh, Sheng‐Kai Hsu, Tzu‐Yu Liu, Chang‐Yi Wu, Chien‐Chih Chiu · 2024 · Cancer Cell International
  20. The Role of MUC1 in Renal Cell Carcinoma
    Martina Milella, Monica Rutigliano, Francesco M. Lasorsa, Matteo Ferro, Roberto Bianchi, Giuseppe Fallara, Felice Crocetto, Savio Domenico Pandolfo, Biagio Barone, Antonio d’Amati et al. · 2024 · Biomolecules
  21. Harnessing exosomes as cancer biomarkers in clinical oncology
    Subhrojyoti Ghosh, Ramya Lakshmi Rajendran, Atharva Anand Mahajan, Ankita Chowdhury, Aishi Bera, Sudeepta Guha, Kashmira Chakraborty, Rajanyaa Chowdhury, Aritra Paul, Shreya Jha et al. · 2024 · Cancer Cell International
  22. Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer
    Ru M. Wen, Jessica C. Stark, G. Edward Marti, Zenghua Fan, Aram Lyu, Fernando Jose Garcia-Marques, Xiangyue Zhang, Nicholas McIlvain Riley, Sarah M. Totten, Abel Bermudez et al. · 2024 · Journal of Clinical Investigation
  23. Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
    Shen Zhao, Ying Cheng, Qiming Jane Wang, Xingya Li, Jun Liao, Jordi Ahnert Rodon, Xiangjiao Meng, Yongzhong Luo, Zhendong Chen, Wei Wang et al. · 2025 · Nature Medicine
  24. Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies
    Valencia Mc Neil, Seung Won Lee · 2025 · Cancers
  25. Financial Toxicity and Its Association With Health-Related Quality of Life Among Partners of Colorectal Cancer Survivors
    Lauren Victoria Ghazal, Paul H. Abrahamse, Kevin C. Ward, Arden M. Morris, Sarah T. Hawley, Christine Marie Veenstra · 2023 · JAMA Network Open
  26. Synergizing the enhanced RIME with fuzzy K-nearest neighbor for diagnose of pulmonary hypertension
    Xiaoming Yu, Wenxiang Qin, Xiao Lin, Zhuohan Shan, Liyao Huang, Qike Shao, Liangxing Wang, Mayun Chen · 2023 · Computers in Biology and Medicine
  27. Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response
    Rong Tang, Jin Xu, Wei Wang, Qingcai Meng, Chenghao Shao, Yiyin Zhang, Yubin Lei, Zi-Feng Zhang, Yuan Liu, Qiong Du et al. · 2023 · Cell Reports Medicine
  28. Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs
    Xiaojun Shi, Shiyu Pang, Jiawei Zhou, Guang Yan, Ruxi Gao, Haowei Wu, Zhou Wang, Yuqing Wei, Xinyu Liu, Wanlong Tan · 2024 · Molecular Cancer
  29. Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers
    Monali Praharaj, Fan Shen, Alex J. Lee, Liang Zhao, Thomas R. Nirschl, Debebe Theodros, Alok Kumar Singh, Xiaoxu Wang, Kenneth M. Adusei, Kara A. Lombardo et al. · 2024 · Cancer Immunology Research
  30. Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
    Chengpei Zhu, Chenchen Zhang, Shanshan Wang, Ziyu Xun, Dongya Zhang, Zhou Lan, Longhao Zhang, Jiashuo Chao, Yajun Liang, Zilun Pu et al. · 2024 · Journal for ImmunoTherapy of Cancer
  31. Joint association of physical activity and dietary quality with survival among US cancer survivors: a population-based cohort study
    Xiaoyuan Wei, Yu Min, Zhongzheng Xiang, Yuanyuan Zeng, Jun Wang, Lei Liu · 2024 · International Journal of Surgery
  32. DSU-Net: Dual-Stage U-Net based on CNN and Transformer for skin lesion segmentation
    Longwei Zhong, Tian-Song Li, Meng Cui, Shao-Guo Cui, Hong-Kui Wang, Li Yu · 2025 · Biomedical Signal Processing and Control
  33. Plant-mediated gold nanoparticles in cancer therapy: exploring anti-cancer mechanisms, drug delivery applications, and future prospects
    Nisha Nisha, Rohan Samir Kumar Sachan, Anjuvan Singh, Arun Karnwal, Amrullah Shidiki, Gaurav Kumar · 2024 · Frontiers in Nanotechnology
  34. Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
    Daniel M. Geynisman, Philip H. Abbosh, Eric A. Ross, Matthew R. Zibelman, Pooja Ghatalia, Fern M. Anari, James Ryan Mark, Lambros Stamatakis, Jean H. Hoffman-Censits, Rosalia Viterbo et al. · 2024 · Journal of Clinical Oncology
  35. An optimized ensemble model based on meta-heuristic algorithms for effective detection and classification of breast tumors
    Abeer Saber, Samar Elbedwehy, Wael A. Awad, Esraa Hassan · 2024 · Neural Computing and Applications
  36. Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis
    Yuqiu Li, Miao Li, Kangtai Su, Siwen Zong, Hongyan Zhang, Lixia Xiong · 2023 · Theranostics
  37. Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
    Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, Padmavati Sahare, Surajit Pathak, Antara Banerjee, Asim K. Duttaroy, Sujay Paul · 2023 · Frontiers in Bioengineering and Biotechnology
  38. Branched-chain amino acids catabolism and cancer progression: focus on therapeutic interventions
    Er Xu, Bangju Ji, Ketao Jin, Yefeng Chen · 2023 · Frontiers in Oncology
  39. Microbiome as a biomarker and therapeutic target in pancreatic cancer
    Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, Mahshid Arastonejad, Sara Naghizadeh Kashani, Roozbeh Pourali, Mina Maftooh, Hamed Akbarzade, Hamid Fiuji, Seyed Mahdi Hassanian et al. · 2024 · BMC Microbiology
  40. Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX
    Venkatesan Saravanan, Bharath Kumar Chagaleti, Shakthi Devi Packiapalavesam, Muthukumaradoss Kathiravan · 2024 · RSC Advances
  41. Advancing nanotechnology for neoantigen-based cancer theranostics.
    Jian-Hua Zou, Yu Zhang, Yuanbo Pan, Zheng-Wei Mao, Xiao-Yuan Chen · 2024 · Chemical Society Reviews
  42. Thermophoretic glycan profiling of extracellular vesicles for triple-negative breast cancer management
    Yike Li, Shaohua Zhang, Chao Liu, Jinqi Deng, Fei Tian, Qiang Feng, Lili Qin, Lixiao Bai, Ting Fu, Liqin Zhang et al. · 2024 · Nature Communications
  43. Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma
    Glenn J. Hanna, Michael J. Dennis, Nicole Scarfo, Michelle S. Mullin, Rosh K.V. Sethi, Kartik Sehgal, Donald J. Annino, Laura A. Goguen, Robert I. Haddad, Roy B. Tishler et al. · 2024 · Clinical Cancer Research
  44. Overcoming therapy resistance in pancreatic cancer: New insights and future directions
    Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, Irina Sarró, Daniel Öhlund · 2024 · Biochemical Pharmacology
  45. Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development
    Ashish Kumar Yadav, Rajesh Kushwaha, Arif Ali Mandal, Apurba Mandal, Samya Banerjee · 2025 · Journal of the American Chemical Society
  46. Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses
    Shengshan Xu, Zizhou Chen, Xiguang Chen, Hongyu Chu, Xufeng Huang, Chunyu Chen, Hejie Liu, Ying Qu, Zhuming Lu · 2025 · BMC Cancer
  47. Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation
    Anshu Agarwal, Vikash Kansal, Humaira Farooqi, Ram Prasad, Vijay Kumar Singh · 2023 · Biomedicines
  48. Biogenic Synthesis of Cu-Mn Bimetallic Nanoparticles Using Pumpkin Seeds Extract and Their Characterization and Anticancer Efficacy
    Nouf Omar Alafaleq, Torki A. Zughaibi, Nasimudeen R. Jabir, Azhar Ullah Khan, Mohd Shahnawaz Khan, Shams S. M. Tabrez · 2023 · Nanomaterials
  49. Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness
    Júlia C.F. Quintanilha, Michael Harrison Storandt, Ryon P. Graf, Gerald Li, Rachel Beth Keller, Douglas I. Lin, Jeffrey S. Ross, Richard S.P. Huang, Alexa Betzig Schrock, Geoffrey R. Oxnard et al. · 2023 · JCO Precision Oncology
  50. Time trend of global uterine cancer burden: an age-period-cohort analysis from 1990 to 2019 and predictions in a 25-year period
    Liu Yang, Yue Yuan, Rongyan Zhu, Xuehong Zhang · 2023 · BMC Women s Health
  51. Current research status of tumor cell biomarker detection
    Liying Jiang, Xinyi Lin, Fenghua Chen, Xiaoyun Qin, Yanxia Yan, Linjiao Ren, Hongyu Yu, Lingqian Chang, Yang Wang · 2023 · Microsystems & Nanoengineering
  52. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer
    Xiu-Rui Hsu, Jiaen Wu, Yi-Ying Wu, Sheng‐Yen Hsiao, Jui‐Lin Liang, Ya-Ju Wu, Chia-Hao Tung, Meng‐Fan Huang, Ming-Shiu Lin, Pan‐Chyr Yang et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  53. Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential
    Ngoc Thi Minh Dinh, Tuan Minh Nguyen, Mi Kyung Park, Chang Hoon Lee · 2024 · International Journal of Molecular Sciences
  54. Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiology
    Juan Carlos Laguna, Miguel García-Pardo, Joao V. Alessi, Carlos H. Barrios, Navneet Singh, Humaid Obaid Al-Shamsi, Herbert Ho-Fung Loong, Miquel Ferriol, Gonzalo Recondo, Laura Mezquita · 2024 · Therapeutic Advances in Medical Oncology
  55. Factors Influencing Social Isolation among Cancer Patients: A Systematic Review
    Can Wang, Xiaoke Qiu, Xueli Yang, Jiayu Mao, Qiuping Li · 2024 · Healthcare
  56. Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
    Zhuo Yan, Zhengbo Zhang, Yanan Chen, Jianghua Xu, Jilong Wang, Z W Wang · 2024 · Cancer Cell International
  57. Development of a Terahertz Metamaterial Micro-Biosensor for Ultrasensitive Multispectral Detection of Early Stage Cervical Cancer
    Musa N. Hamza, Mohammad Tariqul Islam, Sunil Lavadiya, Iftikhar Ud Din, Bruno Cavalcante de Souza Sanches, Slawomir Marcin Koziel, Syeda Iffat Naqvi, Ali Farmani, Md. Shabiul Islam · 2024 · IEEE Sensors Journal
  58. Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations
    Maha AlDoughaim, Nada Alsuhebany, Mohammed Alzahrani, Tariq Alqahtani, Sahar S. Alghamdi, Hisham A. Badreldin, Hana Al Alshaykh · 2024 · Clinical Medicine Insights Oncology
  59. Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8 + T cells
    Ke Nan, Ziwen Zhong, Ying Yue, Yang Shen, Hao Zhang, Zhiqiang Wang, Kameina Zhuma, Baichao Yu, Ying Fu, Luman Wang et al. · 2025 · Gut
  60. PSMA PET imaging in the diagnosis and management of prostate cancer
    Sina Houshmand, Courtney A. Lawhn-Heath, Spencer C. Behr · 2023 · Abdominal Radiology
  61. Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers
    Gabriela Vanessa Flores Monar, Thomas R. Reynolds, Maxie Gordon, David Moon, Chulso Moon · 2023 · International Journal of Molecular Sciences
  62. An Activatable Near‐Infrared Fluorescent Probe for Precise Detection of the Pulmonary Metastatic Tumors: A Traditional Molecule Having a Stunning Turn
    Qian Jia, Ruili Zhang, Haohao Yan, Yanbin Feng, Fang Sun, Zuo Yang, Chaoqiang Qiao, Xiaocheng Mou, Jie Tian, Zhongliang Wang · 2023 · Angewandte Chemie International Edition
  63. High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer
    Xavier Bessa, Joana Vidal, Joan Carles Balboa, C. Márquez, Sven Duenwald, Yupeng He, Victoria M. Raymond, Iris Faull, Andrea Burón, C. Álvarez-Urturi et al. · 2023 · Annals of Oncology
  64. Emerging Multifunctional Carbon‐Nanomaterial‐Based Biosensors for Cancer Diagnosis
    Jolitta Sheri John Britto, Xinwei Guan, Thi Kim Anh Tran, Zhihao Lei, Rohan Bahadur, Vaishwik Patel, Xiangwei Zhang, Sharon L. Wong, Ajayan Vinu · 2024 · Small Science
  65. Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions
    Rohan Kalyan Rej, Joyeeta Roy, Srinivasa Rao Allu · 2024 · Cancers
  66. Roles of microbiota in pancreatic cancer development and treatment
    Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani · 2024 · Gut Microbes
  67. Crosstalk between CAFs and tumour cells in head and neck cancer
    Xinyang Li, Celia González-Maroto, Mahvash Tavassoli · 2024 · Cell Death Discovery
  68. PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer
    Fabrice Barlési, Byoung Chul Cho, Sarah B. Goldberg, Kiyotaka Yoh, Ana Caroline Zimmer Gelatti, Helen Mann, Aarthi Gopinathan, Zofia Felicja Bielecka, Michael Newton, Charu Aggarwal · 2024 · Future Oncology
  69. Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy
    Alessandra Giordano, Anna Chiara Provenza, Giorgio Reverchon, Lucia Baldino, Ernesto Reverchon · 2024 · Pharmaceutics
  70. Deep-Learning-Based Automated Identification and Visualization of Oral Cancer in Optical Coherence Tomography Images
    Zihan Yang, Hongming Pan, Jianwei Shang, Jun Zhang, Yanmei Liang · 2023 · Biomedicines
  71. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives
    Hamid Aria, Marzieh Rezaei · 2023 · Biomedicine & Pharmacotherapy
  72. Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
    Zhi Gang Xu, Yafei Zhuang, Qingtai Chen · 2023 · European Journal of Medicinal Chemistry
  73. Advances in the treatment of metastatic prostate cancer
    Georges Gebrael, Gliceida Galarza Fortuna, Nicolas Sayegh, Umang Swami, Neeraj Agarwal · 2023 · Trends in cancer
  74. Molecular Docking and Molecular Dynamics Studies Reveal the Anticancer Potential of Medicinal-Plant-Derived Lignans as MDM2-P53 Interaction Inhibitors
    Tagyedeen H. Shoaib, Nihal Abdelmoniem, Rua M. Mukhtar, Amal Th. Alqhtani, Abdullah L. Alalawi, Razan Alawaji, Mashael S. Althubyani, Shaimaa G. A. Mohamed, Gamal Abdallah Mohamed, Sabrin R. M. Ibrahim et al. · 2023 · Molecules
  75. AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
    Olivier Nolan-Stevaux, Cong Li, Lingming Liang, Jinghui Zhan, Juan Estrada, Tao Osgood, Fei Li, Hanzhi Zhang, Ryan B. Case, Christopher M. Murawsky et al. · 2023 · Cancer Discovery
  76. Temporal Trends in Mortality of Critically Ill Patients with Sepsis in the United Kingdom, 1988–2019
    Hallie C. Prescott, David A Harrison, Kathy Rowan, Manu Shankar‐Hari, Hannah Wunsch · 2024 · American Journal of Respiratory and Critical Care Medicine
  77. Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
    Bishal Gyawali, Christopher M. Booth · 2024 · The Lancet Oncology
  78. A review on magnetic beads-based SELEX technologies: Applications from small to large target molecules
    Ioana Manea, Magdolna Casian, Oana Hosu, Noemı́ de-los-Santos-Álvarez, Marı́a Jesús Lobo-Castañón, Cécilia Cristea · 2024 · Analytica Chimica Acta
  79. Genomic hallmarks and therapeutic targets of ribosome biogenesis in cancer
    Yue Zang, Ran Xia, Jie Yuan, Hao Wu, Youya Wang, He Li, Huajing Teng, Zhongsheng Sun · 2024 · Briefings in Bioinformatics
  80. ImmunoPET imaging of Trop2 in patients with solid tumours
    Wei Huang, You Zhang, Min Cao, Yanfei Wu, Feng Jiao, Zhaohui Chu, Xinyuan Zhou, Lianghua Li, Dongsheng Xu, Xinbing Pan et al. · 2024 · EMBO Molecular Medicine
  81. Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
    Fei Feng, Yue Zhao · 2024 · Medical Principles and Practice
  82. Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment
    Wen Tong, Tianze Wang, Yi Bai, Xingpeng Yang, Pinsheng Han, Liuyang Zhu, Yamin Zhang, Zhongyang Shen · 2024 · Journal of Translational Medicine
  83. Boundary-Guided and Region-Aware Network With Global Scale-Adaptive for Accurate Segmentation of Breast Tumors in Ultrasound Images
    Kai Hu, Xiang Zhang, Dongjin Lee, Dapeng Xiong, Yuan Zhang, Xieping Gao · 2023 · IEEE Journal of Biomedical and Health Informatics
  84. The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion
    Jian Zhong Yang, Ying Liu, Shi Liu · 2023 · Cell Death and Disease
  85. Trends in Uterine Cancer Mortality in the United States
    Sahana Somasegar, Aya Bashi, Susan M. Lang, Cheng-I Liao, C. A. Johnson, Kathleen M. Darcy, Chunqiao Tian, Daniel Stuart Kapp, John K. Chan · 2023 · Obstetrics and Gynecology
  86. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles
    Jiaxin Zhang, Kaicheng Zhou, Jingbo Lin, Xianxian Yao, Dianwen Ju, Xian Liang Zeng, Zhiqing Pang, Wuli Yang · 2023 · Biomaterials
  87. Advancements in SERS‐based biological detection and its application and perspectives in pancreatic cancer
    Lei Xu, Yujiao Xie, Jie Lin, Aiguo Wu, Tianan Jiang · 2023 · Open Research (University of Surrey)
  88. PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
    Rahul Raj Aggarwal, Glenn Heller, David W. Hillman, Han Xiao, Joel Picus, Mary‐Ellen Taplin, Tanya Barauskas Dorff, Leonard Joseph Appleman, Douglas Jay Weckstein, Akash Patnaik et al. · 2024 · Journal of Clinical Oncology
  89. Circulating tumour DNA-Based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis
    Jiachun Zheng, Chuling Qin, Qianxi Wang, Dongbo Tian, Zisheng Chen · 2024 · EBioMedicine
  90. Recent advances and clinical challenges of phototherapeutic nanoparticles in cancer monotherapy or combination therapy
    Yuanying Zhang, Yanling Zhang, Gege Zhang, Jiahui Wu, Lingling Wang, Ziyi Dong, Yi Zheng, Qiong Huang, Mi Zou, Rui Liao et al. · 2024 · Coordination Chemistry Reviews
  91. The new advance of exosome-based liquid biopsy for cancer diagnosis
    Haozhou Tang, Dan Bi Yu, Jiahui Zhang, Maoye Wang, Min Fu, Qian Yu, Xiao-Xin Zhang, Runbi Ji, Jianmei Gu, Xu Zhang · 2024 · Journal of Nanobiotechnology
  92. Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis
    Luca Mastrantoni, Marta Chiaravalli, Alexia Spring, Viria Beccia, Armando Di Bello, Cinzia Bagalá, Maria Bensi, Diletta Barone, Giovanni Trovato, Giulia Caira et al. · 2024 · The Lancet Oncology
  93. Deep learning models in classifying primary bone tumors and bone infections based on radiographs
    Hua Wang, Yu He, Lu Wan, Chenbei Li, Zhaoqi Li, Zhihong Li, Haodong Xu, Chao Tu · 2025 · npj Precision Oncology
  94. A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy.
    Martyna Nowak-Perlak, P. Ziólkowski, M. Woźniak · 2023 · Phytomedicine
  95. Bioorthogonal “Click and Release” Reaction‐Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy
    Xiao Yan, Ke Li, Tian‐Qiu Xie, Xiao‐Kang Jin, Cheng Zhang, Qian‐Ru Li, Jun Xiang Feng, Chuan‐Jun Liu, Xian‐Zheng Zhang · 2024 · Angewandte Chemie International Edition
  96. ANXA3-Rich Exosomes Derived from Tumor-Associated Macrophages Regulate Ferroptosis and Lymphatic Metastasis of Laryngeal Squamous Cell Carcinoma
    Licheng Xu, Wenjing Li, Danxi Liu, Jing Cao, Jingchun Ge, Xinyu Liu, Yue Wang, Yujian Teng, Pengyan Liu, Xinyue Guo et al. · 2024 · Cancer Immunology Research
  97. Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer
    Yiran Liang, Fangzhou Ye, Dan Luo, Li Long, Yajie Wang, Yuhan Jin, Lei Wang, Yaming Li, Dianwen Han, Bing Chen et al. · 2024 · Molecular Cancer
  98. Dinuclear Tridentate Ru(II) Complex with Strong Near-Infrared Light-Triggered Anticancer Activity
    Wei Li, Rajesh Kushwaha, Tumpa Sadhukhan, Haorui Wu, Anyi Dao, Zhishang Zhang, Haotu Zhu, Qiufang Gong, Jiaxi Ru, Chao Liang et al. · 2024 · Journal of Medicinal Chemistry
  99. Pancreatic cancer cell-derived migrasomes promote cancer progression by fostering an immunosuppressive tumor microenvironment
    Ronghua Zhang, Junya Peng, Yalu Zhang, Kexin Zheng, Yang Chen, Lulu Liu, Tong Li, Tong Li, Ying Li, Sen Yang et al. · 2024 · Cancer Letters
  100. Tumor-microenvironment-on-a-chip: the construction and application
    Hanzheng Xu, Jiangtao Wen, Jiahua Yang, Shufen Zhou, Yijie Li, Ke Xu, Wei Li, Sen Li · 2024 · Cell Communication and Signaling